Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06477172 · ClinicalTrials.gov registry record
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
A clinical trial of Post Procedural Erythema, sponsored by Acorn Biolabs.
- Recruiting
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT06477172: Recruiting study of Post Procedural Erythema, sponsored by Acorn Biolabs.
NCT06477172 is a study of Post Procedural Erythema that is actively recruiting participants, run by Acorn Biolabs. The registered enrollment target is 500 participants. The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06477172, a study of Post Procedural Erythema, is actively recruiting participants, sponsored by Acorn Biolabs.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
Primary Outcome
Symptoms of redness, swelling, oozing, pain, tenderness, crusting, itching and discoloration will be measured using a 1-10 likert scale with 0 being best possible and 10 being worst imaginable.
Conditions Studied
Study Locations (20)
California
- Arash Moradzadeh MD - Beverly Hills
- Glenn Vallecillos, MD Inc - Beverly Hills
- Behr Laser & Skin Care Center - Fresno
- Aesthetics By Dr. Lee - Granite Bay
- Carlo Honrado, MD, FACS - Los Angeles
- Marcus Medical - Manhattan Beach
- N2 Aesthetics - Manhattan Beach
- Marina Plastic Surgery - Marina del Rey
- M Beauty by Tess - San Diego
- Modern Aesthetics - Walnut Creek
- Dr. Christie - West Hollywood
- Ziering Medical - West Hollywood
Florida
- Bauman Medical - Boca Raton
- Mirror Plastic Surgery - St. Petersburg
Alabama
- Skin Wellness Dermatology - Birmingham
Arizona
- BelleSante - Scottsdale
Colorado
- BEAUTY by BUFORD - Lone Tree
Illinois
- Hive Aesthetic LLC - Chicago
Indiana
- Chernoff Cosmetic Surgery - Indianapolis
Michigan
- ICON Antiaging & Aesthetics - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2027-02 |
What NCT06477172 shows while recruiting
NCT06477172 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Post Procedural Erythema appearing as the primary indexed condition, and to 0 interventions.
NCT06477172 names 20 study sites across 8 states, led by California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT06477172 about?
NCT06477172 is a clinical study titled "Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures". Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
What is the current status of trial NCT06477172?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-09-09. Estimated completion is 2027-02.
What conditions does trial NCT06477172 study?
This clinical trial studies the following conditions: Post Procedural Erythema.
Who is sponsoring clinical trial NCT06477172?
This trial is sponsored by Acorn Biolabs, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06477172 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI